ZA891502B - Sulphated k5 antigen and sulphated k5 antigen fragments - Google Patents

Sulphated k5 antigen and sulphated k5 antigen fragments

Info

Publication number
ZA891502B
ZA891502B ZA891502A ZA891502A ZA891502B ZA 891502 B ZA891502 B ZA 891502B ZA 891502 A ZA891502 A ZA 891502A ZA 891502 A ZA891502 A ZA 891502A ZA 891502 B ZA891502 B ZA 891502B
Authority
ZA
South Africa
Prior art keywords
sulphated
antigen
fragments
antigen fragments
Prior art date
Application number
ZA891502A
Other languages
English (en)
Inventor
Constant Adriaan Anton Boeckel
Adriaan Anton Van Boe Constant
Gijsbert Willem Karel Va Dedem
Willem Karel Van Dede Gijsbert
Neeltje Anna Kraayeveld
Anna Kraayeveld Neeltje
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of ZA891502B publication Critical patent/ZA891502B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
ZA891502A 1988-03-10 1989-02-27 Sulphated k5 antigen and sulphated k5 antigen fragments ZA891502B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8800597 1988-03-10

Publications (1)

Publication Number Publication Date
ZA891502B true ZA891502B (en) 1989-11-29

Family

ID=19851917

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA891502A ZA891502B (en) 1988-03-10 1989-02-27 Sulphated k5 antigen and sulphated k5 antigen fragments

Country Status (10)

Country Link
US (1) US5071969A (de)
EP (1) EP0333243A3 (de)
JP (1) JPH01282201A (de)
KR (1) KR890014128A (de)
AU (1) AU609586B2 (de)
DK (1) DK115189A (de)
FI (1) FI891131A (de)
NZ (1) NZ228271A (de)
PT (1) PT89958A (de)
ZA (1) ZA891502B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0798588B2 (ja) * 1986-10-13 1995-10-25 ニチデン機械株式会社 リ−ドフレ−ム分離装置
IE64378B1 (en) * 1990-04-23 1995-07-26 Akzo Nv Carbohydrate derivatives comprising a trisaccharide unit
FR2669932B1 (fr) * 1990-12-03 1994-07-01 Sanofi Sa Nouvel heparosane-n,o-sulfate, son procede de preparation et les compositions pharmaceutiques qui le contiennent.
GB2254083A (en) * 1991-03-28 1992-09-30 Italfarmaco Spa Anticoagulants from e.coli saccharide
FR2684385B1 (fr) * 1991-11-28 1997-08-01 Sanofi Elf Heparosanes-n,o-sulfates de haute masse moleculaire, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2687686B1 (fr) * 1992-02-26 1994-05-27 Sanofi Elf Enzyme destinee a la fragmentation du n-acetylheparosane, obtention des preparations contenant cette enzyme et procedes de fragmentation utilisant cette enzyme.
DE4312476A1 (de) * 1993-04-16 1994-10-20 Kolbus Gmbh & Co Kg Vorrichtung zum Vereinzeln von Bogen eines Bogenstapels
US5514665A (en) * 1993-12-30 1996-05-07 University Of British Columbia Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
IT1289613B1 (it) * 1997-02-07 1998-10-15 Inalco Spa Polisaccaridi batterici o-solfatati
IT1290814B1 (it) * 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
ITMI991465A1 (it) * 1999-07-02 2001-01-02 Inalco Spa Processo per la preparazione dei polisaccaridi k4 e k5 da escherichiacoli
ES2423888T3 (es) 2001-09-07 2013-09-25 Alchemia Limited Pentasacáridos de heparina sintéticos
WO2003106505A1 (en) * 2002-06-18 2003-12-24 Pasqua Anna Oreste Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained
US20120253029A1 (en) 2002-06-18 2012-10-04 Pasqua Anna Oreste Process for the preparation of highly o-sulfated epimerized derivatives of k5 polysaccharide and intermediates therein
JP2006291102A (ja) * 2005-04-13 2006-10-26 National Institute Of Advanced Industrial & Technology 精製オリゴ糖画分
EP1872791A1 (de) 2006-06-30 2008-01-02 Institut Pasteur Verwendung von Polysacchariden bakteriellen Ursprungs zur Hemmung der Bildung von Biofilmen
FR2949114B1 (fr) * 2009-08-14 2011-08-26 Sanofi Aventis OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3265781D1 (en) * 1981-05-21 1985-10-03 Akzo Nv New anti-thromboticum based on polysacharides, method for its preparation and pharmaceutical compositions
GB2128617A (en) * 1982-10-06 1984-05-02 Martti Vaara Polypeptides for use in antibacterial therapy
EP0158291A3 (de) * 1984-04-10 1988-07-27 Takeda Chemical Industries, Ltd. Verfahren zur Reinigung von karzinoembryonischem Antigen und Verfahren zur Herstellung eines monoklonalen Antikörpers, der mit karzinoembryonischem Antigen reagiert
GR860379B (en) * 1985-02-22 1986-06-11 Akzo Nv Novel disaccharide and trisaccharide derivatives of the lipid a type
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
EP0240098A3 (de) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo und Polysaccharide zur Behandlung von Krankheiten verursacht durch Retroviren
EP0300099A1 (de) * 1987-07-20 1989-01-25 Akzo N.V. Pentasaccharide

Also Published As

Publication number Publication date
DK115189A (da) 1989-09-11
FI891131A0 (fi) 1989-03-09
JPH01282201A (ja) 1989-11-14
NZ228271A (en) 1991-05-28
AU609586B2 (en) 1991-05-02
DK115189D0 (da) 1989-03-09
FI891131A (fi) 1989-09-11
EP0333243A3 (de) 1989-09-27
AU3090189A (en) 1989-09-21
KR890014128A (ko) 1989-10-21
EP0333243A2 (de) 1989-09-20
US5071969A (en) 1991-12-10
PT89958A (pt) 1989-11-10

Similar Documents

Publication Publication Date Title
DK151589A (da) Ultrasonisk behandling af dyr
ZA891502B (en) Sulphated k5 antigen and sulphated k5 antigen fragments
GB8812514D0 (en) Portable chamberpot
NZ224046A (en) Hiv antigenic peptide fragments and their use
GB8801107D0 (en) Fingernail repair
GB2232138B (en) Escape chute
AU6909191A (en) Improved cd-30 antibodies and fragments thereof
IL85955A0 (en) Human tumor-associated antigen
EP0414066A3 (en) Polyesters and polyestercarbonates
GB8806874D0 (en) Arbitrary shaped clipper
IL91892A0 (en) Classifying objects
DK501989A (da) Mikrobiocidt praeparat og dettes fremstilling
GB9010381D0 (en) Hair-styling device and method
GB2229089B (en) Portable seating
GB8922142D0 (en) Trapdoors
EP0336100A3 (en) Refixation nail
IE890644L (en) Sulphated k5 antigen
GR890100675A (en) Aryloxyaldehydes and their manufacture
ZA897772B (en) Organotinfluorides and their manufacture
EP0423333A4 (en) Anti-endoserine antibody
KR900701387A (ko) 겔조 성물 및 네일폴리쉬
ZA905763B (en) Novel antigens and methods therefor
CS539588A1 (en) Cascade impactor
GB8910170D0 (en) Improvements in reflectors
IE880458L (en) Virus antigen